GI-2024-22-reg2: Regulations Amending the Cannabis Regulations (Harmonization with Certain Provisions of the Controlled Substances Regulations)

Businesses affected include licensed cannabis drug producers, pharmacists, hospitals, licensed dealers (including those specialized in destruction), and analytical testing licence holders. Cannabis drug licence holders will need to update their record-keeping and destruction procedures to align with new terminology and requirements, such as using 'brand name' and 'drug identification number' in records. Pharmacists gain new flexibility to sell or distribute prescription cannabis drugs to other pharmacists outside of emergency situations, but must comply with updated written order and record-keeping requirements. Licensed dealers specialized in destruction face new formal obligations around witnessing, attestation, and record retention for cannabis drug destruction. The RIAS for this regulation is contained within the companion Controlled Substances Regulations, so specific cost estimates are not available here.